1999
DOI: 10.1006/bbrc.1998.0124
|View full text |Cite
|
Sign up to set email alerts
|

Antioxidant Agent Nimesulid and β-Blocker Metoprolol Do Not Exert Protective Effects against Rat Mitochondrial DNA Alterations in Adriamycin-Induced Cardiotoxicity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
14
0
1

Year Published

2002
2002
2015
2015

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 18 publications
(18 citation statements)
references
References 26 publications
3
14
0
1
Order By: Relevance
“…This increase in cardiac enzyme could be due to an increase in their release following DOX treatment. Data presented here is consistent with those previously reported [9][10][11][12][13]. Interestingly, administration of AG to DOX-treated mice resulted in approximately complete reversal of the DOX-induced increase in serum CK.…”
Section: Discussionsupporting
confidence: 93%
See 2 more Smart Citations
“…This increase in cardiac enzyme could be due to an increase in their release following DOX treatment. Data presented here is consistent with those previously reported [9][10][11][12][13]. Interestingly, administration of AG to DOX-treated mice resulted in approximately complete reversal of the DOX-induced increase in serum CK.…”
Section: Discussionsupporting
confidence: 93%
“…Efforts have been focused on using antioxidants to protect the heart against DOX toxicity. However, the results were not encouraging since most of these agents only decrease or delay the development of cardiomyopathy and do not provide complete protection [10,12,13,15,16].…”
Section: Introductionmentioning
confidence: 96%
See 1 more Smart Citation
“…Several compounds with antioxidant properties, e.g., Trolox, and 5-aminosalicylic acid (5-ASA), have been investigated in vitro and in vivo with some degree of success (DeAtley et al, 1999;Van Vleet et al, 1980). Molecules with in vitro antioxidant effect such as selenium (Van Vleet et al, 1980) or nimesulid (Kotsinas et al, 1999) could not reduce the Dox cardiotoxicity in vivo. Dexrazoxane, an iron chelator with potent antioxidant properties, is the only United States Food and Drug Administration (USFDA) approved drug used for preventing Dox-induced cardiotoxicity.…”
Section: +mentioning
confidence: 99%
“…4 It is now clear that COX-2 is an inducible immediate early gene, 11 involved not only in inflammation and cell proliferation 11 but also in differentiation, 12 apoptosis, 13 metastasis, 14 immunologic surveillance 15 and angiogenesis. 16 Nimesulide, a preferential COX-2 inhibitor of nonsteroidal antiinflammatory drugs (NSAIDs), 17 inhibits chemically induced colon, 18,19 mammary, 20 tongue 21 and urinary bladder 22 carcinogenesis in rats. However, it is still important to examine the modifying effects of nimesulide on pancreatic carcinogenesis because the postinitiation and promotion stages are supposed to be organspecific.…”
mentioning
confidence: 99%